Issue 2/2021
Content (25 Articles)
Emerging issues related to COVID-19 vaccination in patients with cancer
Kamal S. Saini, Diogo Martins-Branco, Marco Tagliamento, Laura Vidal, Navneet Singh, Kevin Punie, Monika Lamba Saini, Isagani Chico, Giuseppe Curigliano, Evandro de Azambuja, Matteo Lambertini
Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based Strategies
Suresh Subramanian, Madhava B. Mallia, Ajit S. Shinto, Ashwathy S. Mathew
How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer
Michael Untch, Miguel Martin, Michelino De Laurentiis, Joseph Gligorov
A Narrative Review of Implementing Precision Oncology in Metastatic Castration-Resistant Prostate Cancer in Emerging Countries
Shouki Bazarbashi, Wen-Pin Su, Siew W. Wong, Ramanujam A. Singarachari, Sudhir Rawal, Maria I. Volkova, Diogo A. Bastos
Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies
Thomas D. Rodgers, Carla Casulo, Frederic Boissard, Aino Launonen, Joana Parreira, Guillaume Cartron
An In-Depth Review of Niraparib in Ovarian Cancer: Mechanism of Action, Clinical Efficacy and Future Directions
Melek Akay, Ionut-Gabriel Funingana, Grisma Patel, Rami Mustapha, Ernese Gjafa, Tony Ng, Kenrick Ng, Michael J. Flynn
What is the Definition of Cure in Non-small Cell Lung Cancer?
Helen Morgan, Libby Ellis, Emma L. O’Dowd, Rachael L. Murray, Richard Hubbard, David R. Baldwin
Does Breast Cancer Surgery Impact Functional Status and Independence in Older Patients? A Narrative Review
Zoe Chia, Ruth M. Parks, Kwok-Leung Cheung
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Jamie Burgess, Maryam Ferdousi, David Gosal, Cheng Boon, Kohei Matsumoto, Anne Marshall, Tony Mak, Andrew Marshall, Bernhard Frank, Rayaz A. Malik, Uazman Alam
Recommendations for Specimen and Therapy Selection in Colorectal Cancer
Snehal B. Patel, Robert Bookstein, Navid Farahani, Myriam Chevarie-Davis, Andy Pao, Angela Aguiluz, Christian Riley, Jennelle C. Hodge, Serhan Alkan, Zhenqui Liu, Nan Deng, Jean R. Lopategui
Incidence and Risk Factors of Pneumonitis in Patients with Non-Small Cell Lung Cancer: An Observational Analysis of Real-World Data
Jerzy E. Tyczynski, Ravi Potluri, Ryan Kilpatrick, Debasish Mazumder, Anirban Ghosh, Alexander Liede
A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy
Chin-Chou Wang, Li-Chung Chiu, Pi-Hung Tung, Scott Chih-Hsi Kuo, Chia-Hsun Chu, Allen Chung-Cheng Huang, Chih-Liang Wang, Chih-Hung Chen, Cheng-Ta Yang, Ping-Chih Hsu
Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Barbara D. Cruz, Mariana M. Barbosa, Lucas L. Torres, Pamela S. Azevedo, Vânia E. A. Silva, Brian Godman, Juliana Alvares-Teodoro
Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating Mutations
Jerry Li, Dana Nickens, Keith Wilner, Weiwei Tan
Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs
Euphemia Leung, Jinal Patel, Jennifer A. Hollywood, Ayesha Zafar, Petr Tomek, David Barker, Lisa I. Pilkington, Michelle van Rensburg, Ries J. Langley, Nuala A. Helsby, Christopher J. Squire, Bruce C. Baguley, William A. Denny, Jóhannes Reynisson, Ivanhoe K. H. Leung
Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview Study
Nikunj Patel, Xandra Lie, Chad Gwaltney, Nana Rokutanda, Afsaneh Barzi, Davide Melisi, Teresa Macarulla, Makoto Ueno, Seung Tae Kim, Oren Meyers, Christina Workman, Melinda Bachini, Gordon Cohen
A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status
Jenna M. Collins, Beth L. Nordstrom, Kimmie K. McLaurin, Tapashi B. Dalvi, Susan C. McCutcheon, James C. Bennett, Brian R. Murphy, Puneet K. Singhal, Charles McCrea, Reshma Shinde, Josefa M. Briceno
Understanding the Patient Experience in NUT Carcinoma: Qualitative Interviews with Patients and Caregivers to Develop a Conceptual Framework
Farrah Pompilus, Anna Ciesluk, Patrick Marquis, Ingolf Griebsch, Maarten Voorhaar
A Cost Impact Analysis of clonoSEQ® as a Valid and CE-Certified Minimal Residual Disease (MRD) Diagnostic Compared to No MRD Testing in Multiple Myeloma in Germany
Stefan Walzer, Sebastian Krenberger, Lutz Vollmer, Tony Hewitt, Benjamin Eckert
Differential Levels of mRNAs in Normal B Lymphocytes, Monoclonal B Lymphocytosis and Chronic Lymphocytic Leukemia Cells from the Same Family Identify Susceptibility Genes
Abdullah Alshahrani, Kristen K. Skarratt, Kristy P. Robledo, Maryam Hassanvand, Benjamin Tang, Stephen J. Fuller
18F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12)
Masato Nakamura, Hironaga Satake, Tamotsu Sagawa, Akinori Takagane, Takashi Sekikawa, Kazuhiro Oguchi, Tomohito Kaji, Masahiro Takeuchi, Wataru Ichikawa, Masashi Fujii
Response to PD-1-Based Immunotherapy for Non-Small Cell Lung Cancer Altered by Gut Microbiota
Daqiang He, Xing Li, Rui An, Lihong Wang, Yun Wang, Song Zheng, Xueqing Chen, Xianjun Wang
Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US
Sundar Jagannath, Nedra Joseph, Jinghua He, Concetta Crivera, Alex Z. Fu, Ashraf Garret, Nina Shah
Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway
Anne-Tove Brenne, Erik Torbjørn Løhre, Anne Kari Knudsen, Morten Thronæs, Jo-Åsmund Lund, Nina Kongshaug, Marte Nilssen Neverdal, Kristina Rystad, Marianne Haug Johansen, Tone Inga Braseth, Stein Kaasa